Company news
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) news
Olema Pharmaceuticals, Inc. news releases on 6ix. Latest, Nov 10, 2021: Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate…
Press releases — page 3
Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 9, 2021
Olema Oncology to Present at Two Upcoming Investor Conferences
November 8, 2021
Olema Oncology Announces Trials in Progress Poster on OP-1250 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 29, 2021
Olema Oncology to Present Data on OP-1250 at the 2021 JCA-AACR Precision Cancer Medicine International Conference
September 8, 2021
Olema Oncology to Present at Morgan Stanley 19th Annual Global Healthcare Conference
August 29, 2021
Olema Oncology Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 9, 2021
Olema Oncology to Present at Canaccord Genuity 41st Annual Growth Conference
July 27, 2021
Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference
May 17, 2021
Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 10, 2021
Olema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors
April 5, 2021
Olema Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates
March 16, 2021
Olema Oncology Announces Late-Breaking Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021
March 9, 2021
Olema Oncology to Participate at Upcoming Virtual Investor Conferences
February 22, 2021
Olema Oncology to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference
December 16, 2020
Olema Oncology Announces Two Poster Presentations at the San Antonio Breast Cancer Symposium 2020
December 6, 2020
Olema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 22, 2020